OR WAIT 15 SECS
© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
September 20, 2020
Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.
September 13, 2020
A session at MSVirtual2020 covers the difficulty of finding treatments for some forms of MS.
September 02, 2020
The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.
August 27, 2020
But there are plenty of holdouts. Half of submissions are still done by phone or fax.
August 08, 2020
Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.
August 05, 2020
The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.
August 04, 2020
Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.
July 30, 2020
Advocates say a number of regulatory changes could help bring more of these products on to the market.
July 18, 2020
Heart disease drugs were in the news this week.
July 11, 2020
Drug development in key areas of unmet need hit milestones this week, with Biogen, AstraZeneca, and Jaguar Health announcing regulatory steps with the FDA.
July 05, 2020
FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.
June 30, 2020
FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.
June 28, 2020
An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.
January 31, 2020
New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.
January 11, 2020
Novel drugs, value-based contracting, biosimilars, and regulatory activity addressing costs will be among the hot button issues in the coming year.
November 29, 2018
In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?
November 28, 2018
Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.
August 02, 2018
April 26, 2018
November 07, 2017
Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.